Table 2

Baseline imaging assessment

All
(n=37)
Acute myocardial infarction group
(n=21)
Chronic total occlusion group
(n=7)
Control group
(n=9)
p Value*
CMR imaging
 LVEF (%)58±1052±962±865±5<0.001
 LV mass (indexed, g/m2)79±2085±2066±1775±160.07
 LVEDV (mL/m2)77±1880±1869±1376±170.35
 LVESV (mL/m2)34±1339±1430±1027±90.046
 WMI0.25±0.130.40±0.200.09±0.050.0±0.0<0.001
 ECV (%)31±534±428±328±2<0.001
 Presence of LGE27 (73)21 (100)6 (86)0 (0)<0.001
 Infarct size (g/m2)8±812±78±80±0<0.001
PET imaging
 SUVmean (kBq/mL)
  SVC2.73±0.512.85±0.512.57±0.392.58±0.570.27
  Total LV uptake2.24±0.512.33±0.481.96±0.531.77±0.27<0.001
  Myocardial infarct uptake3.23±1.033.72±0.631.76±0.26<0.001
  Remote myocardial uptake2.21±0.602.41±0.571.62±0.140.001
 TBRmean
  Total LV uptake0.77±0.160.82±0.180.71±0.060.70±0.030.08
  Myocardial infarct uptake1.05±0.371.34±0.220.70±0.14<0.001
  Remote myocardial uptake0.80±0.180.85±0.170.64±0.120.009
 SUVmax (kBq/mL)
  Total LV uptake2.71±0.582.86±0.562.24±0.402.07±0.31<0.001
  Myocardial infarct uptake3.53±1.003.98±0.682.18±0.35<0.001
  Remote myocardial uptake2.59±0.642.75±0.652.18±0.350.02
 TBRmax
  Total LV uptake0.98±0.191.02±0.190.89±0.200.81±0.090.01
  Myocardial infarct uptake1.28±0.341.42±0.250.86±0.16<0.001
  Remote myocardial uptake0.94±0.190.97±0.200.84±0.130.11
 SUVC (kBq/mL)
  Total LV uptake−0.55±0.57−0.52±0.55−0.61±0.670.81±0.420.85
  Myocardial infarct uptake0.75±0.911.13±0.67−0.40±0.46<0.001
  Remote myocardial uptake−0.19±0.52−0.11±0.54−0.45±0.370.12
  • *Analysis of variance, Student’s t-test (continuous data) or χ2 test (categorical data).

  • Mean±SD or number (percentage).

  • CMR, cardiac magnetic resonance; ECV, extracellular volume; LGE, late gadolinium enhancement; LV, left ventricular; LVEDV, LV end diastolic volume; LVEF, LV ejection fraction; LVESV, LV end systolic volume; PET, positron emission tomography; SUV, standardised uptake value; SUVC, corrected SUV; SUVmax, maximum SUV; SVC, superior vena cava; TBR, tissue-to-background ratio; WMI, wall motion index.